Michelle Hammer speaks on a Panel at Bristol Meyers Squibb
Michelle Hammer speaks on a Panel at Bristol Meyers Squibb Michelle spoke on a panel at Bristol Meyers Squibb as the patient advocate at the launch of the new schizophrenia medication COBENFY. Cobenfy™ is a newly approved medication for the treatment of schizophrenia in adults. Unlike traditional antipsychotics, which target dopamine receptors, Cobenfy [...]